THALIDOMIDE AND THALIDOMIDE ANALOGUES FOR THE STIMULATION OF STEM CELL FACTOR

摘要

The present invention relates to the administration of thalidomide and/or thalidomide analogues to a patient to enhance or maintain endogenous levels of stem cell factor in a patient to prevent and/or treat medical conditions associated with declining endogenous stem cell factor levels also known as mast cell growth factor or kit-ligand.